AAAAAA
Results:
1-14
|
Results: 14
Authors:
Hansen, KE
Kong, DF
Moore, KD
Ortel, TL
Citation: Ke. Hansen et al., Risk factors associated with thrombosis in patients with antiphospholipid antibodies, J RHEUMATOL, 28(9), 2001, pp. 2018-2024
Authors:
Kong, DF
Blazing, MA
O'Connor, CM
Citation: Df. Kong et al., Advances in the approach to acute coronary syndromes, HOSP PRACT, 35(4), 2000, pp. 61
Authors:
Borges-Neto, S
Javaid, A
Shaw, LK
Kong, DF
Hanson, MW
Pagnanelli, RA
Ravizzini, G
Coleman, RE
Citation: S. Borges-neto et al., Poststress measurements of left ventricular function with gated perfusion SPECT: Comparison with resting measurements by using a same-day perfusion-function protocol, RADIOLOGY, 215(2), 2000, pp. 529-533
Authors:
Cohen, MG
Kong, DF
Warner, JJ
Wightman, MB
Greenbaum, AB
Tcheng, JE
Peter, RH
Sketch, MH
Muhlbaier, LH
Zidar, JP
Citation: Mg. Cohen et al., Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents, AM J CARD, 85(4), 2000, pp. 446-450
Authors:
Kong, DF
Califf, RM
Citation: Df. Kong et Rm. Califf, Coronary interventions "to go": Is faster better?, J INVAS CAR, 11(6), 1999, pp. 401-402
Authors:
Cohen, MG
Granger, CB
Ohman, EM
Stebbins, AL
Grinfeld, LR
Cagide, AM
Elizari, MV
Betriu, A
Kong, DF
Topol, EJ
Califf, RM
Citation: Mg. Cohen et al., Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction - Results from the GUSTO-I and -III trials, J AM COL C, 34(6), 1999, pp. 1729-1737
Authors:
Kong, DF
Califf, RM
Citation: Df. Kong et Rm. Califf, Glycoprotein IIb/IIIa receptor antagonists in non-ST elevation acute coronary syndromes and percutaneous revascularisation - A review of trial reports, DRUGS, 58(4), 1999, pp. 609-620
Authors:
Kong, DF
Topol, EJ
Bittl, JA
White, HD
Theroux, P
Hasselblad, V
Califf, RM
Citation: Df. Kong et al., Clinical outcomes of bivalirudin for ischemic heart disease, CIRCULATION, 100(20), 1999, pp. 2049-2053
Authors:
Tcheng, JE
Kong, DF
Citation: Je. Tcheng et Df. Kong, Vale, warfarin: A stentorian farewell, AM HEART J, 138(4), 1999, pp. 602-605
Authors:
Kong, DF
Citation: Df. Kong, Steroids for restenosis: Strike three!, AM HEART J, 138(1), 1999, pp. 3-4
Authors:
Sadowski, ZP
Alexander, JH
Skrabucha, B
Dyduszynski, A
Kuch, J
Nartowicz, E
Swiatecka, G
Kong, DF
Granger, CB
Citation: Zp. Sadowski et al., Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction, AM HEART J, 137(5), 1999, pp. 792-798
Authors:
Alexander, JH
Kong, DF
Cantor, WJ
Citation: Jh. Alexander et al., Highlights from the 71st American Heart Association Scientific Sessions: November 8 to 11, 1998, AM HEART J, 137(3), 1999, pp. 555-574
Authors:
Califf, RM
Kong, DF
Citation: Rm. Califf et Df. Kong, The future of glycoprotein IIb/IIIa inhibitors, CONTEMP CAR, 2, 1999, pp. 327-360
Authors:
Kong, DF
Califf, RM
Miller, DP
Moliterno, DJ
White, HD
Harrington, RA
Tcheng, JE
Lincoff, AM
Hasselblad, V
Topol, EJ
Citation: Df. Kong et al., Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease, CIRCULATION, 98(25), 1998, pp. 2829-2835
Risultati:
1-14
|